This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Childhood immunisations

Authoring team

UK's routine childhood immunisation programme (1)

 

  1. intramuscular injection into deltoid muscle in upper arm or anterolateral aspect of the thigh
  2. rotavirus vaccine should only be given after checking for a severe combined immunodeficiency (SCID) screening result
  3. contains porcine gelatine
  4. see annual flu letter (https://www.gov.uk/government/collections/annual-flu-programme)
  5. if LAIV (live attenuated influenza vaccine) is contraindicated or otherwise unsuitable use inactivated flu vaccine (check Green Book chapter 19 (https://www.gov.uk/government/publications/influenza-the-green-book-chapter-19) for details)
  6. see Green Book chapter 18a (https://www.gov.uk/government/publications/human-papillomavirus-hpv-the-green-book-chapter-18a) for immunising immunocompromised young people who will need 3 doses
  7. take blood for HBsAg at 12 months to exclude infection
  8. in addition hexavalent vaccine (Infanrix hexa or Vaxelis) is given at 8, 12 and 16 weeks
  9. check SCID screening outcome before giving BCG
  10. where the annual incidence of TB is >= 40/100,000 – see Tuberculosis by country: rates per 100,000 people (https://www.gov.uk/government/publications/tuberculosis-tb-by-country-rates-per-100000-people)

Reference:

  1. UK Health Security Agency. Routine childhood immunisations from 1 July 2024.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.